Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Inv. presentation
Mersana Therapeutics, Inc. (MRSN) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/08/2023 8-K Quarterly results
Docs: "Mersana Therapeutics Announces Second Quarter 2023 Financial Results"
07/27/2023 8-K Results of Operations and Financial Condition, Cost Associated with Exit or Disposal Activities, Regulation FD Disclosure, Ot...
Docs: "Mersana Therapeutics Announces Topline Data from UPLIFT Clinical Trial in Patients with Platinum-Resistant Ovarian Cancer and Strategic Reprioritization"
06/09/2023 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders...
Docs: "FIFTH AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF MERSANA THERAPEUTICS, INC."
05/09/2023 8-K Quarterly results
Docs: "Mersana Therapeutics Provides Business Update and Announces First Quarter 2023 Financial Results"
03/31/2023 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits  ...
Docs: "MERSANA THERAPEUTICS, INC. SECOND AMENDED AND RESTATED BYLAWS SECTION 1 - STOCKHOLDERS Section 1.1. Annual Meeting . An annual meeting of the stockholders of Mersana Therapeutics, Inc., a Delaware corporation , for the election of directors to succeed those whose terms expire and for the transaction of such other business as may properly come before the meeting shall be held at the place, if any, within or without the State of Delaware, on the date and at the hour that the Board of Directors of the Corporation shall each year fix. Unless stated otherwise in the notice of the annual meeting of the stockholders of the Corporation, such annual meeting shall be at the principal office of the Corporation. Section 1.2. Nominations of Directors . Nominations for election to the Board of Directors..."
03/24/2023 8-K Entry into a Material Definitive Agreement  Interactive Data
03/13/2023 8-K Regulation FD Disclosure, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Mersana Therapeutics Provides Statement About SVB",
"Mersana Therapeutics Announces Clinical Hold on XMT-2056 Phase 1 Clinical Trial"
02/28/2023 8-K Quarterly results
Docs: "Mersana Therapeutics Provides Business Update and Announces Fourth Quarter and Full Year 2022 Financial Results"
02/01/2023 8-K Quarterly results
01/25/2023 8-K Regulation FD Disclosure, Other Events, Financial Statements and Exhibits  Interactive Data
01/06/2023 8-K Results of Operations and Financial Condition, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits ...
Docs: "Mersana Therapeutics Provides Business Update and Announces Strategic Objectives and Expected Milestones"
12/27/2022 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
12/22/2022 8-K Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits  Inte...
11/07/2022 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
Docs: "SALES AGREEMENT",
"Letter re: Prospectus Supplement to Registration Statement on Form S-3"
11/07/2022 8-K Quarterly results
Docs: "Mersana Therapeutics Provides Business Update and Announces Third Quarter 2022 Financial Results"
10/06/2022 8-K Quarterly results
08/16/2022 8-K Quarterly results
08/08/2022 8-K Quarterly results
08/08/2022 8-K Quarterly results
06/10/2022 8-K Quarterly results
05/09/2022 8-K Quarterly results
02/28/2022 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
Docs: "SALES AGREEMENT",
"Letter re: Prospectus Supplement to Registration Statement on Form S-3"
02/28/2022 8-K Quarterly results
02/03/2022 8-K Quarterly results
11/23/2021 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
11/09/2021 8-K Quarterly results
Docs: "Mersana Therapeutics Announces Third Quarter 2021 Financial Results and Provides Business Update"
10/29/2021 8-K Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Creation of a Direct Financial Ob...
09/10/2021 8-K Investor presentation
Docs: "Corporate presentation"
08/16/2021 8-K Quarterly results
08/06/2021 8-K Quarterly results
06/17/2021 8-K Quarterly results
05/10/2021 8-K Quarterly results
04/09/2021 8-K Quarterly results
03/11/2021 8-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy